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The generation of natural regulatory T cells
(nTregs) is crucial for the establishment
of immunologic self-tolerance and the
prevention of autoimmunity. Still, the
origin of nTregs and the mechanisms
governing their differentiation within the
thymus are poorly understood, particu-
larly in humans. It was recently shown
that conventional dendritic cells (cDCs)
in human thymus were capable of induc-
ing nTreg differentiation. However, the
function of plasmacytoid DCs (pDCs), the
other major subset of thymic DCs, re-
mains unknown. Here we report that pDCs
resident in the human thymus, when acti-
vated with CD40 ligand (CD40L) plus inter-
leukin-3, efficiently promoted the genera-
tion of CD4CD25Foxp3 nTregs from
autologous thymocytes. The progenitors
of these nTregs were selectively found
within CD4CD8 thymocytes that had
accomplished positive selection, as
judged by their CD69hiTCRhi phenotype.
Supporting the involvement of the CD40-
CD40L pathway in pDC-induced nTreg
generation, we show that positively se-
lected CD4CD8 progenitors specifi-
cally transcribed CD40L in vivo and up-
regulated CD40L expression on T-cell
receptor engagement, thereby promoting
the activation of pDCs. Finally, evidence
is provided that nTregs primed by pDCs
displayed reciprocal interleukin-10/trans-
forming growth factor- cytokine expres-
sion profiles compared with nTregs
primed by cDCs. This functional diversity
further supports a nonredundant tolero-
genic role for thymic pDCs in the human
thymus. (Blood. 2010;115(26):5366-5375)
Introduction
Dendritic cells (DCs) are highly specialized antigen-presenting
cells (APCs) that are crucial in the regulation of innate and adaptive
immunity. DCs respond to danger signals by antigen uptake,
maturation, and induction of antigen-specific immune responses in
secondary lymphoid organs.1,2 In addition, tissue DCs are able to
present antigen in a tolerogenic fashion, leading to anergy or
deletion of potentially self-reactive T cells, or inducing the
generation of regulatory T cells (Tregs).3-6 Tregs play a key role in
the control of immune homeostasis and immunologic tolerance and
are crucial to protect against fatal autoimmunity throughout life.
Tregs also regulate or suppress other classes of immune responses,
such as allograft rejection, allergy, tumor immunity, and responses
to microbes.7,8 Thus, there is great interest in understanding how do
Tregs develop.
During thymopoiesis, nearly all positively selected CD4CD8
double-positive (DP) thymocytes carrying high-affinity T-cell
receptors (TCRs) for self-peptide-major histocompatibility com-
plexes are eliminated by a mechanism of clonal deletion that
ensures central tolerance.6 Self-reactive thymocytes that escape
clonal deletion undergo an alternative process of nondeletional
tolerance that involves their positive selection and further differen-
tiation into immunosuppressive CD4 T cells, termed natural Tregs
(nTregs).8-11 In addition, Tregs can be induced in the periphery
(iTregs) from CD4 T lymphocytes.4 Generation of thymic nTregs
critically involves the interleukin-2 receptor- chain (CD25), the
transcription factor Foxp3, and the costimulatory molecule
CD28,12-14 as genetic defects in these molecules impair nTreg
generation, leading to systemic autoimmunity.15-17
Despite the crucial function of nTregs, the exact nature of the
nTreg progenitors and the mechanisms by which self-reactive
thymocytes are diverted into the Treg lineage remain unclear.
Several studies in mice suggest that thymic epithelial cells (TECs)
regulate positive selection of nTreg progenitors with TCRs recog-
nizing self-antigens with moderate to high avidity below the
threshold of negative selection.9,11,18 DCs can also function as
efficient tolerogenic APCs in the mouse thymus.19 In humans,
Watanabe et al20 found that thymic DCs were able to induce the
generation of nTregs from allogeneic CD4CD25 single-positive
(SP) thymocytes in response to thymic stromal-derived lymphopoi-
etin (TSLP) produced by Hassal corpuscle TECs. Of the 2 major
subsets of thymic DCs, ie, plasmacytoid DCs (pDCs) and conven-
tional DCs (cDCs),21-23 TSLP-responsive DCs belong to the
latter.20 However, no function has been established for thymic
pDCs, although the tolerogenic role of pDCs as inducers of Tregs in
the periphery has been illustrated.24-26 Therefore, the contribution
of thymic pDCs to the development of nTregs remains to be
determined in both mouse and human. In addition, it is important to
establish the cellular origin of nTreg progenitors and the nature of
signals involved in their development.
The present work was aimed at investigating the possible tolerogenic
function of human thymic pDCs, the molecular mechanisms underlying
the generation of human nTregs, and the identity of the physiologic
progenitors of nTregs in the human thymus. Our results provide
evidence that pDCs resident in the human thymus are efficient
tolerogenic DCs, able to induce the differentiation of positively
selected CD69hiTCRhiCD4CD8 DP autologous thymocytes into
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nTregs. Moreover, our data suggest that CD40 ligand (CD40L)-
dependent crosstalk between pDCs and nTreg precursors may be
involved in that process.
Methods
DC isolation, flow cytometry, and culture
Experiments were performed in accordance with procedures approved by
the Spanish Research Council Bioethics Committee. Human postnatal
thymocytes were isolated from thymus fragments removed during correc-
tive cardiac surgery of patients 1 month to 4 years of age, after informed
consent was provided in accordance with the Declaration of Helsinki.
Thymocyte suspensions enriched in non-T cells by sheep erythrocyte
rosetting27 were depleted of monocyte/macrophages by anti-CD14 bead
magnetic sorting (autoMACS, Miltenyi Biotec). Flow cytometry was
performed in a FACSCalibur (BD Biosciences) on electronically gated
CD123CD13, CD123loCD13, and CD123loCD13 cells using phyco-
erythrin (PE)–conjugated anti-CD123 and PE-Cy5–coupled anti-CD13
monoclonal antibodies (mAbs; Beckman Coulter) in combination with
either fluorescein isothiocyanate (FITC)–conjugated or unlabeled mAbs
against BDCA2 (Miltenyi Biotec), CD11c, CD45RA, and CD45RO
(Caltag), and CD86, CD80, and HLA-DR (BD Biosciences). Secondary
reagents were FITC-coupled goat anti–mouse Igs (Caltag). Irrelevant
isotype-matched antibodies (Caltag) were used as controls. Sorting of pDCs
and cDCs was performed using PE-conjugated mAbs against CD123 and
CD13 (BD Biosciences), respectively, plus anti-PE–coupled beads (Milte-
nyi Biotec). DC maturation was induced after 24 hours of culture in RPMI
1640 (BioWhittaker) medium supplemented with 10% fetal calf serum
(Invitrogen) and either 2.5 ng/mL recombinant human (rh) CD40L (R&D
Systems) plus 60 ng/mL rhIL-3 (National Institute of Biochemical Stan-
dards and Controls) or 15 ng/mL rhTSLP (R&D Systems), and assessed by
flow cytometry using FITC-conjugated anti-CD86 and PE-Cy5–conjugated
anti-CD80 mAbs (BD Biosciences).
Isolation of thymocytes and peripheral T lymphocytes
CD4CD8CD25 SP thymocytes were sorted using anti-CD8 and anti-
CD4 multisort beads (Miltenyi Biotec) and PE-conjugated anti-CD25 mAb
(BD Biosciences) plus anti-PE beads. Large- (L) and small-sized (S) DP
subsets were selected using Percoll density gradients (GE Healthcare; 1.068
and 1.08 densities, respectively).28 Further enrichment in CD69hi or CD69lo
cells was performed by AutoMACs sorting using PE-conjugated anti-CD69
mAb (Caltag) and anti-PE beads. For isolation of CD4CD25 T cells,
peripheral blood (PB) mononuclear cells were labeled with PE-conjugated
mAbs against CD8, CD15, CD19, and CD56 (Caltag), and against CD13,
CD14, CD25, CD33, and CD123 (BD Biosciences), and then depleted of
PE-labeled cells with anti-PE beads. CD4 cells were then isolated by
positive selection with anti-CD4 beads to reach more than 95% purity.
In vitro generation of Tregs
Autologous or allogeneic CD4CD25 SP thymocytes, or allogeneic
CD4CD25 PB T cells (105 cells/well) were cocultured with either
primary immature pDCs or CD40L plus IL3-cultured mature pDCs in
round-bottomed 96-well culture plates at a final 2:1 T/DC ratio. T-cell
proliferation was assessed by carboxyfluorescein succinimidyl ester (CFSE)
labeling (Invitrogen). S-DP CD69lo, L-DP CD69hi, or L-DP CD69lo
thymocytes (105cells/well) were cocultured with either mature pDCs or
TSLP-activated cDCs, at a final 2:1 DP thymocyte/DC ratio. To preserve
DP thymocyte viability, cocultures were set up in flat-bottomed 96-well
culture plates onto a monolayer of OP9 stromal cells supplemented with
0.5 ng/mL rhIL-7 (National Institute of Biochemical Standards and
Control), and 20 ng/mL rhIL-2 (NCI Biological Resources Branch) was
added to support Treg generation.11,15 CD25 and Foxp3 expression was
assessed by flow cytometry using APC-conjugated anti-CD25 (eBio-
science) and PE-conjugated anti-Foxp3 (eBioscience) mAbs. For inducible
costimulator (ICOS) expression, an FITC-conjugated anti-ICOS antibody29
was used. When indicated, cocultures were supplemented every other day
with blocking mAbs against ICOS ligand (ICOSL, 2 g/mL; eBioscience),
CD86 (5 g/mL), or CD80 (5 g/mL) (BD Biosciences), or with anti-CD86
plus anti-CD80 mAbs (5 g/mL each). Isotyped-matched control antibod-
ies (5 g/mL) were from Caltag.
Functional Treg assays
CD4 PB T cells, or L-DP CD69hi, L-DP CD69lo, or S-DP CD69lo
thymocytes cocultured with MpDC or McDC for 7 days were enriched in
CD25hi or CD25lo/ cells by autoMACS sorting. Suppressive potential of
isolated cells was assayed in triplicate by [3H]-thymidine incorporation
after 5 days of coculture with CD4CD25 PB T lymphocytes (1:1 ratio or
as indicated) that were stimulated in flat-bottomed 96-well culture plates
precoated with 10 g/mL anti-CD3 mAb (UCHT1, ATCC-AN1009425)
and supplemented with 2 g/mL anti-CD28 mAb (BD Biosciences) plus
IL-2 (20 ng/mL). To support nTreg cell survival,7 cultures were supple-
mented with 20 ng/mL rhIL-2. In some experiments, the suppression assay
was performed in the presence of neutralizing anti-IL10 (200 ng/mL) plus
anti-IL-10R (10 ng/mL) antibodies (R&D Systems), or transforming
growth factor- (TGF-) R type I kinase (ALK5) inhibitor II (TGF-RI
inhibitor) (1M; Calbiochem), added to the culture every other day.
Irrelevant goat anti–rabbit Igs (200 ng/mL; Jackson ImmunoResearch
Laboratories) and mouse IgG1 (10 ng/mL; Caltag) or dimethyl sulfoxide
were used as controls. Cytokine production was measured in triplicate in
supernatants collected at day 7 of culture, using a human IL-10 enzyme-
linked immunosorbent assay (ELISA) kit (Immunotools) and a human
TGF- ELISArray kit (SA Biosciences).
Induction of CD40L and CD40L-dependent pDC activation
L-DP CD69hi thymocytes were cultured in 24-well culture plates (5 105/well)
either untreated or precoated with anti-CD3 mAb, and supplemented with
anti-CD28 mAbs plus 20 ng/mL rhIL-2. After 16 to 24 hours, CD40L expression
was analyzed by flow cytometry using an APC-conjugated anti-CD40L mAb
(BD Biosciences). Anti-CD3-stimulated or nonstimulated L-DP CD69hi thymo-
cytes were then cocultured for 24 hours with primary thymic pDCs at a final 1:1
ratio in round-bottomed 96-well plates. Activation of pDCs was analyzed by
2-color flow cytometry using anti-CD123 and anti-CD86 mAbs.
Semiquantitative reverse-transcribed polymerase chain
reaction
Total RNA was isolated using TRIzol (Invitrogen) from sorted S-DP
CD69lo, L-DP CD69hi, and L-DP CD69lo thymocytes obtained from the
very same thymus sample. cDNA was generated using oligo-d(T) primers
and Expand Reverse Transcriptase (Roche Diagnostics). Serially diluted
cDNA samples were amplified by polymerase chain reaction using specific
CD40L primers, as described.30 Amplified products were subjected to
agarose electrophoresis and visualized by ethidium bromide. -Actin
amplification was included as control of cDNA loading.
Immunohistochemistry
Frozen thymic sections were fixed on acetone, incubated with goat serum
and avidin/biotin blocking kit (Vector Laboratories), and labeled using
anti–human CD123 (BioLegend) and biotin-conjugated anti–human Foxp3
mAbs (eBioscience). Secondary reagents were Alexa 488–conjugated goat
anti–mouse IgG1 and Alexa 455–conjugated streptavidin (Invitrogen).
TECs were stained with antipan cytokeratin mAbs (Sigma-Aldrich) plus
Alexa 488–conjugated donkey anti–mouse IgGs (Invitrogen). Nuclei were
identified in all sections with TOPRO-3 (Invitrogen). Images were obtained
in a confocal LSM510 (Carl Zeiss) microscope using 10 (numeric
aperture [NA] 0.3), 25 (scan zoom of 2.0, NA 0.8), and 40 (NA 1.3)
magnification and Carl Zeiss LSM510 4.2 software. Image analysis was
performed using the Carl Zeiss LSM Image browser, Version 4.2 software.
Statistics
Statistical significance was determined with the 2-tailed Student t test, with
the  level set at 0.05.
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Results
pDCs and cDCs resident in the human thymus become
activated in response to different stimuli
Thymic pDCs and cDCs can be identified in thymocyte suspen-
sions depleted of monocytes and T-lineage cells by their reciprocal
expression of CD123 versus CD13 (Figure 1A). As shown
previously,21-23 primary thymocytes with high CD123 expression
(0.05% 0.006% of total thymocytes, n 40) lacked CD13
and CD11c myeloid markers but expressed the pDC marker
BDCA2, whereas CD13 cells (0.026% 0.003%) displayed a
BDCA2lo/CD11cCD123lo phenotype characteristic of cDCs
(Figure 1A-B). As expected of pDCs,21-23 CD123CD13 cells
expressed high CD45RA levels but very low CD45RO, whereas
cDCs were homogeneously positive for CD45RO but heteroge-
neous for CD45RA (Figure 1B). Subsets of cDCs and pDCs thus
identified displayed a typical immature DC phenotype, with no
expression of the costimulatory molecule CD80 and weak or
undetectable levels, respectively, of CD86 (Figure 1B). Besides
these 2 DC subsets, we consistently observed a population of
CD13 cells with low CD123 expression (0.062% 0.014%;
Figure 1A), which lacked CD11c and expressed high CD45RA but
weak CD45RO, thus resembling pDCs. However, CD123loCD13
cells displayed up-regulated levels of the activation markers CD80,
CD86, and HLA-DR, but down-regulated BDCA2 expression,
compared with CD123CD13 pDCs (Figure 1B). Because down-
regulation of both CD123 and BDCA2 is a common feature of
human pDC activation,22,31 our results may suggest that the
CD123loCD13 population actually includes activated pDCs.
To assess whether thymic immature pDCs, like their cDC
counterparts,20 could become activated in response to TSLP, both
cell subsets were independently isolated based on their reciprocal
CD123/CD13 expression (96.56% 1.6% and 97.96% 0.9%
purity, respectively; n 4; Figure 1A), and their activation profile
was then analyzed on culture with rhTSLP. As shown in Figure 1C,
absolute pDC numbers decreased up to 4-fold (4.34 1.45; n 3)
after 24 hours of culture, compared with TSLP-treated cDCs, and
induction of pDC maturation was very inefficient, as indicated by
the low numbers of cells that up-regulated CD80 and CD86 (Figure
1D). In contrast, no pDC decrease was found under conventional
pDC activating conditions32 with CD40L plus IL-3 (Figure 1C),
and up-regulation of CD80 and CD86 activation markers was
induced to levels similar to those of TSLP-activated cDCs
(57.6%  7.0% CD86 and 64.8%  10.4% CD80 vs
83.8% 3.1% CD86 and 52.4% 13.1% CD80, respectively;
n  3; Figure 1D). Notably, acquisition of such a pDC mature
phenotype paralleled the formation of characteristic cell aggregates
and the appearance of a distinctive mature DC morphology with
long dendrites (Figure 1E). Therefore, pDCs resident in the human
thymus, in contrast to cDCs, are unresponsive to TSLP but mature
in response to CD40L plus IL-3.
Figure 1. pDCs and cDCs from human thymus
mature in response to different stimuli. (A) CD123
versus CD13 flow cytometry analysis of thymocyte
suspensions depleted of T cells and monocytes/
macrophages shows the presence of CD123CD13
(R1), CD123loCD13 (R2), and CD123loCD13 (R3)
cells (left histogram). Isotyped-matched control Abs
were used to define background staining. Isolation of
pDCs and cDCs was performed by magnetic sorting
based on reciprocal CD123 and CD13 expression.
Postsorting phenotype of one of 10 experiments is
shown (right histogram). (B) Flow cytometry analysis
of BDCA2, CD11c, CD86, CD80, HLADR, CD45RA,
and CD45RO expression in the populations electroni-
cally gated as defined in panel A (shaded histo-
grams). Background staining was defined with iso-
type-matched Abs (empty histograms). Results of 1
of 4 experiments are shown. (C) Cell recoveries of
either pDCs cultured for 24 hours with TSLP or with
CD40L plus IL-3 or cDCs cultured with TSLP. Abso-
lute DC numbers were normalized to 105 input cells.
Data (mean  SD) correspond to 3 independent
experiments. *P 	 .05. (D) pDCs do not mature in
response to TSLP but mature in the presence of
CD40L plus IL-3. Flow cytometry analysis of CD80
and CD86 expression (shaded histograms) of pDCs
and cDCs cultured as described in panel C.
(E) Bright-field microscopy of thymic pDCs cultured
with CD40L plus IL-3 for 24 hours (top, original
magnification 40), showing an amplification of the
lower right inset (bottom).
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Tolerogenic potential of human thymic pDCs
To investigate whether human thymic pDCs could serve a tolero-
genic role, primary immature pDCs and mature pDCs derived from
them on 24 hours of culture with CD40L plus IL-3 (hereafter
referred to as IpDCs and MpDCs, respectively) were analyzed
using the allogeneic assay previously used to characterize tolero-
genic cDCs.20 IpDCs or MpDCs were cocultured with either
CD4CD25 naive T cells from allogeneic PB (CD4PB) or
CD4CD25 SP thymocytes (CD4SP) from allogeneic donors
(supplemental Figure 1, available on the Blood Web site; see the
Supplemental Materials link at the top of the online article), and
both T-cell proliferation and production of CD4CD25Foxp3
Tregs were analyzed at day 7. In addition, autologous CD4SP
thymocytes were used to examine the tolerogenic function of
thymic pDCs under more physiologic conditions. As shown in
Figure 2A, no cell proliferation of either allogeneic or autologous
cells was induced in response to IpDCs, as CFSE intensity was
comparable with that of cultures devoid of pDCs; neither CD25 nor
Foxp3 up-regulation was observed. In contrast, MpDCs induced
the proliferation of a significant fraction of allogeneic CD4PB and
CD4SP cells, whereas proliferation of autologous CD4SP thymo-
cytes was hardly detectable (Figure 2B). In all culture conditions,
cell proliferation correlated with CD25 up-regulation
(47.6% 24%, 39%  24%, and 15.4% 8% of CD25 cells in
CD4PB, allogeneic CD4SP, and autologous CD4SP cultures,
respectively; n 3); so that CD4 proliferating cells were mostly
CD25, whereas CD4 cells lacking CD25 were essentially resting
cells (Figure 2B). Therefore, mature, but not immature, thymic
pDCs induced a conventional allogeneic CD4 T-cell proliferation
response. More importantly, MpDCs specifically induced the
expression of the Treg marker Foxp312 in a variable proportion of
CD4PB and CD4SP allogeneic cells, which displayed high CD25
(CD25hi) expression (Figure 2B-C), although CD25hiFoxp3 cell
generation was consistently more efficient from the latter. How-
ever, no generation of CD25hiFoxp3 cells was observed from
autologous CD4SP thymocytes (Figure 2B). Given that Foxp3 was
undetectable on naive CD4CD25 PB T cells and thymocytes
(supplemental Figure 1) and was not induced on culture with
IpDCs (Figure 2A), our data suggest that thymic MpDCs specifi-
cally promoted Foxp3 up-regulation and differentiation of Tregs.
Formal proof that such CD4CD25hi Foxp3 T cells were Tregs
was provided at the functional level in a conventional suppression
assay. As shown in Figure 2D, sorted CD25hi, but not CD25lo/
cells, derived from CD4PB lymphocytes, significantly inhibited the
proliferation of naive PB CD4 T cells activated with anti-CD3 and
anti-CD28 mAbs plus IL-2 (60.8 9.7 inhibition in 3 experi-
ments). Together, our data indicate that thymic pDCs activated with
CD40L plus IL-3 display tolerogenic potential and can induce the
generation of allogeneic Tregs.
Positively selected CD69hiTCR-hi DP thymocytes in human
thymus develop efficiently into nTregs in response to activated
autologous pDCs
Generation of nTregs under physiologic conditions must be driven
by autologous DCs, but activated pDCs induced few, if any, nTregs
from autologous CD4SP thymocytes (Figure 2B). A possible
explanation for these negative results may rely on the current view
that nTreg thymic progenitors express self-reactive TCRs with
affinities falling within the range between positive selection of
conventional CD4 T cells and negative selection of high-affinity
self-reactive T cells.17 In this scenario, nTreg progenitor frequen-
cies would be expected to be extremely low at the CD4SP stage, but
higher immediately upstream of negative selection, probably at the
stage of CD4CD8 DP TCR- thymocytes, as suggested in
mice.33 To test this hypothesis, we analyzed the nTreg potential of
either activated (positively selected) or nonactivated (nonselected)
DP thymocytes, isolated by Percoll density gradients and cell
sorting.28 Two distinct DP populations were Percoll-isolated,
namely, large- and small-sized DP thymocytes (L-DP and S-DP,
Figure 2. Tolerogenic potential of human thymic pDCs. (A) Ex vivo-isolated
immature thymic pDCs (IpDCs) or (B) pDCs activated in response to CD40L plus IL-3
(MpDCs) were cocultured with CFSE-labeled autologous (Auto) or allogeneic (Allo)
CD4 SP thymocytes (CD4SP) or allogeneic PB CD4 T lymphocytes (Allo CD4PB).
CD25 expression of total cells (left black histograms) and CFSE expression of either
total or electronically gated CD25 and CD25 cells (middle empty histograms) was
analyzed by flow cytometry after 7 days. The CFSE profile of total cells cultured in the
absence of DCs is shown in black. Numbers correspond to total percentages of
CD25 cells. Analysis of CD25 versus Foxp3 expression of total cultured cells is
shown on the right. Numbers correspond to percentages of CD25Foxp3 cells.
Background staining was defined with isotype-matched Abs. Results of 1 of
3 experiments are shown. (C) Relative numbers of CD25Foxp3 cells recovered
from cocultures of either allo CD4SP thymocytes or allo CD4PB lymphocytes with
MpDCs. Data are mean  SEM for 3 independent experiments. *P 	 .05. (D) Sup-
pressive function of CD25hi cells derived from CD4PB lymphocytes primed with
MpDCs. Naive peripheral CD4 T lymphocytes stimulated with anti-CD3 and
anti-CD28 mAbs plus IL-2 (20 ng/mL) were cultured in the absence (control) or
presence of magnetically sorted CD25hi or CD25lo/ cells (upper right histograms).
Data are mean  SEM of [3H]-thymidine incorporation at day 5 of triplicate cultures
(cpm) of 1 of 3 independent experiments. **P 	 .01.
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respectively,
 95% CD4CD8; supplemental Figure 2), which
differed in TCR- cell proportions and TCR- expression
levels. L-DP thymocytes included a minor subset TCR-
(27.3% 6.5%) selectively enriched in cells with high TCR-
expression (TCRhi; log 3 fluorescence intensity [FI]; 42.7% 8.4%
of L-DP TCR- thymocytes). In contrast, S-DP thymocytes
were mostly TCR- cells (65.6% 3.0%), with low to interme-
diate TCR- expression (TCRlo/int; log 1-2 FI). Importantly,
essentially all TCRhi L-DP thymocytes displayed high levels of the
early activation marker CD69 (CD69hi, log 2-3 FI), a phenotype
expected for positively selected DP thymocytes,34 whereas both L
and S TCR-lo/int DP thymocytes were mostly nonactivated cells
with low CD69 (CD69lo, log 1-2 FI; supplemental Figure 2A).
Based on these results, we used CD69 expression levels as a
criterion to further isolate positively selected thymocytes from the
L-DP subset. Accordingly, L-DP thymocytes were enriched in
CD69hi selected cells (referred to as L-DP CD69hi, 62.1% 7.3%
CD69hi within TCR- cells; n 4) by magnetic sorting, whereas
S-DP thymocytes, which were mostly devoid of CD69hi cells
(referred to as S-DP CD69lo; 6.4%  0.9% CD69hi within TCR-
 cells; n 4), remained nonfractionated (Figure 3A left). To
compare the nTreg potential of positively selected versus un-
selected DP thymocytes, L-DP CD69hi and S-DP CD69lo cells were
cocultured with CD40L plus IL-3-activated pDCs isolated from the
same thymus, and their T-cell progeny was analyzed after 7 days by
flow cytometry (Figure 3A right). Primary L-DP CD69hi thymo-
cytes were basically devoid of CD25Foxp3 cells, although they
included a small CD25Foxp3 subset (7.9% 2.3%) whose
relevance as uncommitted nTreg precursors remains unclear35
(supplemental Figure 2B). However, after coculture with activated
pDCs, they gave rise to a significant production of CD25Foxp3
cells both in absolute (supplemental Figure 3) and relative (Figure
3A-B) numbers, which was impaired in the absence of MpDCs,
indicating that pDCs play an active role in inducing the generation
of nTregs. In contrast, few CD25Foxp3 cells were derived from
S-DP CD69lo thymocytes, which were unresponsive to MpDCs, as
judged by their reduced survival and expansion compared with
L-DP CD69hi cells (Figure 3A-B; supplemental Figure 3). Consis-
tent with a true de novo generation of nTregs, acquisition of the
CD25Foxp3 phenotype was accompanied by a sequential down-
regulation of CD8 from L-DP-CD69hi thymocytes, and thereby to
the generation of CD4CD8 cells (Figure 3C). More importantly,
CD8 down-regulation paralleled CD25 and FoxP3 up-regulation,
so that the highest expression of these 2 markers was restricted
to CD4CD8 SP thymocytes. Because generation of
CD25Foxp3CD4 cells was impaired when L-DP thymocytes
were depleted of CD69hi cells (L-DP CD69lo; supplemental Figure
4), our results further indicate that nTreg progenitors in the human
thymus selectively reside within the subset of recently selected
CD69hiTCR-hi DP self-reactive thymocytes.
Thymic pDCs and cDCs drive differentiation of autologous
TCRhiCD69hi DP thymocytes into nTregs with reciprocal
cytokine expression profiles
Next, we compared mature thymic cDCs and pDCs for their
autologous tolerogenic potential. As shown in Figure 4A and B,
both CD40L plus IL-3–activated MpDCs and TSLP-activated
cDCs (referred to as McDCs) were capable of inducing
CD25Foxp3 nTregs from autologous L-DP CD69hi thymocytes.
However, titration analyses using sorted CD25hi cells derived from
Figure 3. MpDCs induce the generation of
CD25Foxp3 natural Tregs from positively selected
CD69hiTCR-hi DP autologous thymocytes. (A) CD69
versus TCR- phenotype of primary large-sized DP
thymocytes enriched in CD69hi cells by magnetic sorting
(L-DP CD69hi) and unselected small-sized DP thymo-
cytes mostly composing CD69lo cells (S-DP CD69lo) (left
histograms, day 0). Numbers indicate percentages of
gated cells. Flow cytometric analysis of Foxp3 versus
CD25 expression on L-DP CD69hi and S-DP CD69lo
thymocytes cultured onto OP9 stromal cells with rhIL-2
plus rhIL-7 for 7 days either in the presence or absence
of autologous MpDCs is shown on the right (day 7).
Numbers in quadrants indicate percentages of
CD25Foxp3 cells. Results are representative of 1 of
3 independent experiments. (B) Relative numbers of
CD25Foxp3 nTregs generated from L-DP CD69hi and
S-DP CD69lo thymocytes cultured as in panel A. Data
are mean  SEM (n  3). *P 	 .05. (C) Flow cytometric
analysis of CD4 (left) or CD8 (right) versus CD25
expression on L-DP CD69hi thymocytes cultured as in
panel A (top panels). Foxp3 expression on electronically
gated CD8hiCD25 (R1), CD8intCD25 (R2), and
CD8CD25 (R3) populations is shown (bottom pan-
els). Numbers indicate MFI values. Results are represen-
tative of 1 of 3 independent experiments.
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either MpDC- or McDC-primed L-DP CD69hi thymocytes (re-
ferred to as CD25hi-pDC or CD25hi-cDCs, respectively; Figure 4B)
showed that the former were more efficient suppressors of CD4
T-cell proliferation (Figure 4C). To further delineate the functional
potential of the 2 nTreg subsets, we assessed their cytokine
expression profiles and found that both nTregs produced IL-10,
although MpDCs-primed nTregs were better producers. Con-
versely, McDCs-primed nTregs produced greater amounts of
TGF- (Figure 4D). Supporting a functional specialization, suppres-
sion activity of CD25hi-pDC nTregs was significantly inhibited by
anti-IL-10 plus anti–IL-10R blocking antibodies, whereas TGF-
RI inhibitor significantly reduced suppression mediated by cDC-
primed CD25hi nTregs (Figure 4E). Therefore, pDCs and cDCs
resident in the human thymus can prime positively selected DP
autologous thymocytes to differentiate into functionally distinct
CD4CD25Foxp3 nTregs.
Generation of human nTreg cells induced by pDCs and cDCs
involves CD80/86 but not ICOSL coreceptors
Two subsets of Treg cells with different IL-10/TGF- expression
potentials have been identified in human thymus and periphery
based on surface expression of ICOS molecule (ICOS and
ICOS).36 Thus, we next analyzed ICOS expression on nTregs
induced by MpDCs or McDCs (Figure 5A). L-DP CD69hi precur-
sors displayed low ICOS expression in vivo (log 1-2 FI), although
somewhat higher than L-DP CD69lo thymocytes (70.6% 5.6% vs
48.9% 10.9% ICOS cells and 11.9 1.3 vs 6.8 1.4 mean FI
[MFI], respectively; Figure 5B). However, ICOS up-regulation was
induced (log 2-3 MFI) on CD25CD4 nTregs derived in the
presence of either McDCs or MpDCs (Figure 5A), although a
slightly higher expression was induced on the former (35.7 6.4
vs 26.9 3.3 MFI, respectively). Importantly, we also identified
2 independent subsets of ICOSlo and ICOS nTregs in the adult
human thymus in vivo (supplemental Figure 5), which may be
equivalent to the ICOS and ICOS thymic subsets reported
before.36 Whereas these data could suggest a functional role of
ICOS and ICOSL in the generation of human nTregs, ICOSL
expression on thymic DCs has not been reported as yet. We found
that ICOSL was up-regulated on maturation on both pDCs and
cDCs (77.5% 18.1% and 74.4% 13.4% respectively; Figure
5C). However, blocking mAbs to ICOSL weakly affected nTreg
generation induced by MpDCs or McDCs, compared with isotype-
matched controls (Figure 5D-E), and a similar effect was observed
with anti-CD80 mAbs. In contrast, generation of nTregs was
markedly impaired by anti-CD86, and simultaneous CD80/CD86
blockade resulted in a synergistic inhibition of up to 80% of nTreg
production (Figure 5D-E), whereas cell recovery of CD25 cells
was unaffected (supplemental Figure 6). Notably, both L-DP
Figure 4. Thymic mature pDCs and cDCs can prime autologous
CD69hiTCR-hi DP thymocytes to differentiate into nTregs with
distinct cytokine expression profiles. (A) Absolute (top panel) and
relative numbers (bottom panel) of CD25Foxp3 cells derived from
CD69hiTCR-hi DP thymocytes cocultured with either MpDCs or McDCs
as described in Figure 3A. Data are mean  SEM (n  4). *P 	 .05.
**P 	 .01. (B) Flow cytometry of CD25 and Foxp3 expression on cells
generated from McDC- or MpDC-primed L-DP CD69hi thymocytes as
described in panel A (top panels) and on the CD25hi-enriched population
isolated from them by magnetic sorting (bottom panels). (C) Suppressive
function of CD25hi cells isolated as in panel B was assessed by [3H]-
thymidine incorporation as described in Figure 2D at the indicated
CD25hi/T-cell ratios Data are mean SD (cpm) of triplicate cultures from a
representative experiment. **P 	 .01. (D) IL-10 and TGF- production by
L-DP CD69hi thymocytes cultured either in the absence or presence of
McDCs or MpDCs as in panel A was assessed by ELISA. Data are
mean  SD (pg/mL) of triplicates for a representative experiment of 3.
*P 	 .05. **P 	 .01. (E). Suppressive function of CD25hi cells generated
from L-DP CD69hi thymocytes on MpDC or McDC priming and isolated as
in panel B was assessed by [3H]-thymidine incorporation at a 1:2
CD25hi/T-cell ratio either in the absence or presence of anti-IL-10 plus
anti-IL-10R blocking Abs or TGF-RI inhibitor. Isotyped-matched Abs and
dimethyl sulfoxide carrier were used as controls. Data represent fold
inhibition of PBCD4 T-cell proliferation normalized to cpm values obtained
in cultures performed in the absence of blocking reagents. Data are
mean  SEM values of triplicate cultures from a representative experi-
ment. **P 	 .01.
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CD69hi and L-DP CD69lo thymocytes expressed the CD28 receptor
of CD80/CD86 (98.9% 0.9% and 95.4% 3.9%, respectively),
although at higher levels on the former (134.5  4.5 vs 60.5 19.9
MFI, respectively; Figure 5B). Collectively, these data support a
functional role of the CD28-CD80/CD86, but not of the ICOS-
ICOSL, signaling pathway in the generation of human nTregs.
TCR-mediated up-regulation of CD40L on nTreg thymic
progenitors induces the activation of autologous pDCs
Next, we sought to get some insights into the physiologic
mechanisms responsible for the generation of tolerogenic pDCs
and the production of nTregs in the human thymus in vivo. To this
end, we searched for putative intrathymic sources of CD40L
production and focused on positively selected L-DP CD69hi nTreg
precursors. Although surface CD40L was hardly detectable on
those cells under steady-state conditions, analysis of CD40L
expression at the transcriptional level showed that CD40L is indeed
selectively transcribed in vivo in the human thymus in L-DP
CD69hi nTreg precursors (Figure 6A-B). Accordingly, a fast
(18-24 hours) CD40L up-regulation was consistently induced
(9.7% 4.2%) on cell activation with anti-CD3 and -CD28 mAbs
plus IL-2 (Figure 6B); these data further support a selective
expression of CD40L on positively selected DP thymocytes. More
importantly, CD40L-expressing L-DP CD69hi thymocytes induced
a significant maturation of thymic pDCs supplemented with IL-3,
whereas a discrete maturation was observed in response to either
nonstimulated L-DP CD69hi thymocytes or IL-3 alone (Figure 6C).
Therefore, TCR engagement on L-DP CD69hi nTreg precursors
may lead to the up-regulation of CD40L, which thereby interacts
with CD40 on thymic pDCs consequently promoting their
maturation.
Plamacytoid DCs and natural Tregs colocalize within the
human thymic medulla
To analyze whether cross-talk between pDCs and nTreg cell
precursors could take place in vivo, we assessed the distribution of
both cell types within the human postnatal thymus. Immunohisto-
chemistry and confocal microscopy of anti–pan-cytokeratin (Cy-
tok) and Topro-3–labeled thymic sections allowed the identifica-
tion of thymic cortex and medulla, as cytokeratin expression is
lower in the former (Figure 7A top panels). Foxp3 nTregs
selectively localized to the thymic medulla (Figure 7A bottom
panels), together with CD123 pDCs (Figure 7B). Notably, interac-
tions between pDCs and Foxp3 cells could be found within the
Figure 5. Differentiation of nTregs from L-DP CD69hi thymocytes
primed with MpDCs or McDCs involves CD80 and CD86 corecep-
tors. (A) Flow cytometric analysis of ICOS versus CD25 expression
on nTregs derived from L-DP CD69hi thymocytes primed with McDCs
or MpDCs as in Figure 4. (B) Flow cytometry analysis of ICOS and
CD28 expression on L-DP CD69hi and L-DP CD69lo primary thymo-
cytes. Numbers indicate percentages of positive cells. MFI values of
CD28 expression are indicated. (C) ICOSL expression analyzed by
flow cytometry on thymic pDCs and cDCs either ex vivo-isolated or
after maturation in vitro. Numbers indicate percentages of positive
cells. Results of one of 3 experiments are shown. (D-E) Effect of
blocking anti-ICOSL, anti-CD80, anti-CD86, or both anti-CD80 and
anti-CD86 mAbs in the generation of Tregs from MpDC- or McDC-
primed L-DP CD69hi thymocytes. Generation of CD25Foxp3 nTregs
was analyzed by flow cytometry at day 7. (D) Data are mean  SEM
of relative numbers of CD25Foxp3 cells normalized to numbers in
control cultures with isotype-matched control antibodies (CAb) (n  3).
*P 	 .05. **P 	 .01. (E) Flow cytometry analysis of CD25Foxp3
cell generation of 1 representative experiment of 3 in panel D.
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medullary area (Figure 7C top left inset). Quantification analysis of
distinct sections showed that 20.9 plus or minus 4.0 of pDCs were
in contact with Foxp3 cells, whereas 7.7 plus or minus 1.7 of
Foxp3 cells interacted with pDCs (Figure 7D). These results
suggest that medullary pDCs could interact with developing
thymocytes and control their differentiation into nTregs in the
steady-state human thymus.
Discussion
In this study, we developed an autologous experimental system that
provided important information on the cellular and molecular
mechanisms underlying generation of nTregs in the human thymus.
We show that thymic pDCs are efficient tolerogenic DCs, able to
induce nTreg generation, and provide evidence that nTreg precur-
sors specifically reside within the subset of positively selected DP
thymocytes expressing high CD69 and TCR- levels.9,34 There-
fore, human nTreg generation may be induced immediately down-
stream of positive selection in recently selected DP thymocytes.
Importantly, pDC-induced nTreg development seems to involve the
CD40-CD40L pathway, as nTreg progenitors up-regulated CD40L
on TCR engagement and induced maturation of pDCs. Given that
mature, but not immature, pDCs induced nTregs, we propose that
CD40-CD40L-mediated cross-talk between pDCs and self-reactive
nTreg precursors may provide critical feedback signals required for
pDC maturation and nTreg differentiation in the steady-state
human thymus.
Besides pDCs, cDCs also induced nTregs from CD69hiTCRhi
DP, but not from CD4CD25 SP, autologous thymocytes, al-
though the latter have been shown to generate nTregs in an
allogeneic setting.20 These data indicate that CD4 SP, but not
CD69hi DP, thymocytes may be devoid of nTreg potential in the
steady-state thymus, as expected of mature thymocytes that have
succeeded negative selection and display a nonautoreactive TCR
repertoire.37 Accordingly, formal evidence has recently been pro-
vided that the efficiency of nTreg generation inversely correlated
with progressive maturation in the murine thymus.38 Therefore,
nTreg cell generation may happen in a narrow developmental
window, immediately downstream of positive selection of those DP
thymocytes that express anti-self-TCRs with moderate to high
avidity below the threshold of negative selection. Because nTreg
generation paralleled a selective expansion of CD25 cells and
Foxp3 nTregs extensively proliferated in our cultures, expansion
of minute numbers of preexisting Foxp3 progenitors cannot be
formally excluded. However, Foxp3 and CD25 were up-regulated
in DP thymocytes, which simultaneously down-regulated CD8,
suggesting that nTreg differentiation occurred de novo.
Figure 6. TCR-mediated activation of L-DP CD69hi thymocyte-expressing
CD40L transcripts leads to CD40L up-regulation and activation of thymic pDCs.
(A) Reverse-transcribed polymerase chain reaction analysis of CD40L mRNA
expression was performed using 2-fold serial dilutions of cDNA from primary S-DP
CD69lo, L-DP CD69hi, and L-DP CD69lo thymocyte populations isolated from the
same thymus sample (top panel). cDNA obtained from phorbol myristate acetate plus
ionomycin-stimulated PB CD4 T lymphocytes was used as a positive control.
(B) Flow cytometry analysis of CD69 versus CD40L expression on primary L-DP
CD69hi thymocytes before culture (left panel), after activation with anti-CD3 and
anti-CD28 mAbs plus IL-2 for 24 hours (middle panel), or after culture in medium
alone (right panel). NS indicates nonstimulated. Numbers in quadrants indicate
percentages of positive cells. (C) Relative numbers of CD86-expressing pDCs after
24 hours of culture with IL-3 in the absence or presence of L-DP CD69hi thymocytes
either stimulated (DPCD40L) or nonstimulated (NS) as in panel A. Data are
mean  SEM (n  3). *P 	 .05. **P 	 .01.
Figure 7. Human Foxp3 nTreg cells colocalize with CD123 pDCs within the
human thymic medulla. (A) Pan-cytokeratin (Cytok, green) immunostaining of
human TECs, and nuclei staining with TOPRO-3 (blue) showing differential expres-
sion of Cytok in thymic medulla (M) and cortex (C). (Top panels) Original magnifica-
tion 10. Bar represents 100 m. Double staining of Cytok (green) and Foxp3 (red)
showing the localization of Foxp3 nTregs in the thymic medulla (bottom panels).
Original magnification 25. Bar represents 50 m. (B-C) Double immunostaining of
CD123 (green) and Foxp3 (red) showing colocalization of pDCs and nTregs within
the thymic medulla (B). Original magnification 10. Bar represents 100 m and
highlighting close interactions among them (C arrows and upper left inset). Original
magnification 40. Bar represents 50 m. (D) Quantification of Foxp3 nTregs
interacting with CD123 pDCs, and vice versa, in the human thymus. Data are
mean  SEM (percent) of interacting cells within 1465 Foxp3 and 518 CD123 cells
in 7 fields from 3 independent tissue sections.
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The nature of thymic APCs that induce nTregs is still
controversial. Some studies showed that Treg development
involved TCR-mediated high-affinity selection on cortical
TECs,9,18 whereas others suggested the participation of a
“saturable” thymic niche with a selective capacity much smaller
than the niche supporting conventional positive selection.39,40
Thus, DCs located in the thymus medulla may represent the
limiting niche providing unique signals for nTreg generation
from self-reactive DP progenitors positively selected by cortical
TECs. Supporting this view, mouse thymic DCs make a
significant contribution to nTreg generation in vivo,19 although
other cell types, such as TECs, may play such an instructive role
in their absence.41 As a whole, available information concurs
with the recent proposal that instructive generation of nTregs
does not require unique features of a dedicated APC, but rather
is dependent on quantitative features of external cues.38
Regarding the DC-derived signals required for nTreg priming,
CD80 and CD86 coreceptors appear critical for the induction of
both pDC- and cDC-primed nTregs, suggesting the participation of
the CD28 pathway in humans, as shown in mice.13 Besides
CD80/86, ICOSL is up-regulated on both pDCs and cDCs on
maturation, although ICOSL expression is specific of pDCs in the
periphery and selectively contributes to the generation of IL-10–
producing Tregs.42 The identification of ICOS and ICOS human
Tregs with a reciprocal pattern of IL-10 and TGF- production36
supports a specific role of the ICOS-ICOSL pathway in priming
IL-10–producing Tregs. In our system, pDC-primed nTregs were
also poised to IL-10 production and IL-10–dependent function,
whereas cDC-induced nTregs were better TGF- producers. How-
ever, thymic pDCs and cDCs appear to control the functional
dichotomy of nTreg cells in an ICOS-ICOSL-independent manner.
Thus, nTreg functional specialization could rely on the capacity of
pDCs and cDCs to induce largely nonoverlapping Treg repertoires
because of their distinct antigen-presenting abilities.43
Thymic pDCs and cDCs were found to become tolerogenic in
response to distinct stimuli, suggesting that specific niches of
mature DCs may be restricted to particular areas of the thymus.
Indeed, cDCs are known to respond to TSLP locally produced by
medullary TECs of Hassal corpuscles.20 However, IL-3 required
for pDC survival is produced by all TECs,44 although CD40L
expression seems restricted to positively selected thymocytes,45
which could then selectively induce pDC maturation in the
medulla. Accordingly, CD40L transcription was confined in vivo to
activated CD69hi DP human thymocytes, which, however, dis-
played undetectable CD40L surface expression. In this regard,
weak but functional CD40L levels could be expressed in vivo on a
restricted CD69hi DP subset, as judged by both the low frequency
of CD40L cells derived from CD69hi DP thymocytes on in vitro
polyclonal activation and their low levels of CD40L expression.
Supporting a regulatory role for CD40L in pDC function, ligation
of CD40 on thymic IpDCs by CD40L, expressed on activated
CD69hi DP thymocytes on TCR engagement, induced pDC matura-
tion and thereby nTreg cell production, at least in vitro. Similarly,
ligation of CD40 is required for maturation of peripheral DCs.2
Therefore, as shown for peripheral Tregs,46,47 the CD40-CD40L
pathway may play a relevant role in nTreg development in the
human thymus, as proposed in mouse.48 Strengthening this possibil-
ity, defective CD40-CD40L signaling leads to autoimmunity in
both humans and mice.46-48 In this scenario, we propose that
recognition of self-peptide-major histocompatibility complexes by
high-affinity TCRs expressed on positively selected DP thymocytes
may be the mechanism that triggers CD40L expression on nTreg
progenitors and leads to feedback maturation of thymic pDCs in
vivo, thereby facilitating a functional cross-talk between pDCs and
developing thymocytes, resulting in terminal nTreg differentiation.
Still, further in vivo studies are required to establish the physi-
ologic relevance of CD40-CD40L in such cross-talk. Our finding,
that a substantial fraction of pDCs in the steady-state human
thymus displays an activated phenotype, suggests that they may
well be capable of inducing nTregs under physiologic conditions.
Nevertheless, the existence of “inducer” stromal cells other than
pDCs cannot be excluded.38 Histologic evidence is provided of
pDC-nTreg colocalization within the human thymic medulla,
which may also support a functional interaction between the 2 cell
types in vivo. However, Foxp3 up-regulation during nTreg develop-
ment takes more than 2 days. Therefore, limitations inherent to the
one-point-in-time histologic technique require dynamic analyses to
clarify whether CD123/Foxp3 colocalization represents long-
lasting interactions between “inducer” pDCs and nTreg progenitors
still in contact. We think that this is probable considering that stable
DC–T-cell interactions can last for longer periods than initially
thought, up to several days, and persistent Treg-DC contacts do
actually precede the inhibition of autoimmune responses in non-
obese diabetic mice.49
The functional role of peripheral pDCs in several physiopatho-
logic situations related to tolerance induction is well estab-
lished.49,50 Still, understanding pDC function in the pathogenesis of
human diseases has just begun. Therefore, understanding how
thymic DCs, either resident or recirculating through the blood,19
control generation of an autologous polyclonal repertoire from
intrathymic progenitors could open new opportunities for the
development of therapeutic strategies to prevent or reverse un-
wanted immunity.
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